{
  "count": 1,
  "data": [
    {
      "id": "hologen",
      "name": "Hologen",
      "short": "Hologen",
      "category": "biotech",
      "founded": 2023,
      "employees": null,
      "funding": "$150M+ (raising Series A)",
      "funding_num_m": 150,
      "valuation": null,
      "focus": "Frontier medical AI · Large Medicine Models · drug development & diagnostics",
      "ethos": "Interventional intelligence for healthcare",
      "hq": "London (UCL/KCL spinout)",
      "key_people": null,
      "milestones": null,
      "founders": null,
      "careers_url": null,
      "created_at": "2026-03-11T13:13:53.429371+00:00",
      "updated_at": "2026-03-11T13:13:53.429371+00:00",
      "ch_number": null,
      "github_org": null,
      "website_url": "https://hologen.ai",
      "twitter": null,
      "linkedin_url": null,
      "logo_url": "https://logo.clearbit.com/hologen.ai",
      "tags": [
        "biotech",
        "drug-discovery",
        "frontier-emerging",
        "health"
      ],
      "description": "Hologen. Frontier medical AI. Large Medicine Models for drug development and diagnostics. UCL/KCL spinout. Co-founded by Eric Schmidt (ex-Google CEO). $200M MeiraGTx partnership for Parkinson's gene therapy. Raising $150M Series A at ~$850M valuation. Tags: biotech, drug-discovery, frontier-emerging, health",
      "clients": "Pharma R&D (MeiraGTx partnership), diagnostics companies"
    }
  ]
}